New and Emerging Bruton Tyrosine Kinase Inhibitors for Treating Mantle Cell Lymphoma – Where Do They Fit In?

Expert Review of Hematology - United Kingdom
doi 10.1080/17474086.2018.1506327
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Informa UK Limited

Related search

Novel Bruton's Tyrosine Kinase Inhibitors Currently in Development

OncoTargets and Therapy
OncologyPharmacology
2013English

Emerging Therapy for the Treatment of Mantle Cell Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

The Proto-Oncogene Mer Tyrosine Kinase Is a Novel Therapeutic Target in Mantle Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

New Molecular Targets in Mantle Cell Lymphoma

Seminars in Cancer Biology
Cancer Research
2011English

New Treatment Options in Mantle Cell Lymphoma

European Oncology and Haematology
OncologyHematology
2015English

Tyrosine Kinase Inhibitors for Diabetes

Science-Business eXchange
2008English

VEGF Kinase Inhibitors: How Do They Cause Hypertension?

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2009English

Bruton Tyrosine Kinase Inhibitor ONO/GS-4059: From Bench to Bedside

Oncotarget
Oncology
2016English

Gamma-Secretase Inhibitors - Do They Have a Role in the Treatment of B Cell Lymphoma?

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy